Related Experiment Video

Updated: Jul 2, 2026

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
07:43

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Published on: September 25, 2018

CGE25-106: MHC II More Effectively Predicts Response to Pembrolizumab Than PD-L1 in HER2 Negative Patients

Emily Fogarty1, Brian Corgiat1, Kayla Sparks1

  • 11Ignite Proteomics, Golden, CO.

Journal of the National Comprehensive Cancer Network : JNCCN
|March 30, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Predictive Immune Modeling of Solid Tumors08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

Related Concept Videos